Contec Medical Systems Co.,Ltd (SHE:300869)
China · Delayed Price · Currency is CNY 11.69
+0.11 (0.95%)
Aug 14, 2026, 3:04 PM CST
SHE:300869 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 456.44 | 468 | 479.81 | 746.9 | 712.11 | 908.71 |
Revenue Growth | -7.32% | -2.46% | -35.76% | 4.88% | -21.63% | -35.15% |
Gross Profit Gross Profit Growth | 182.57 | 195.67 | 123.27 | 387.08 | 330 | 431.83 |
Operating Income Operating Income Growth | -65.83 | -46.1 | -112.03 | 136.38 | 108.55 | 272.7 |
Net Income Net Income Growth | -49.1 | -24.42 | -77.9 | 165.77 | 196.2 | 352.35 |
Earnings Per Share EPS Growth | -0.12 | -0.06 | -0.19 | 0.40 | 0.48 | 0.88 |
EPS Growth | - | - | - | -16.67% | -45.26% | -46.53% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
China China Growth | 152.41 | 125.45 | 403.83 | 230.28 | 173.41 |
Overseas Overseas Growth | 315.6 | 354.35 | 343.08 | 481.83 | 735.3 |
Total Total Growth | 468 | 479.81 | 746.9 | 712.11 | 908.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,053 | 2,026 | 1,108 | 1,963 | 1,926 | 813.96 |
Total Debt Total Debt Growth | 985.26 | 967.48 | 786.77 | 1,048 | 1,576 | 804.33 |
Net Cash (Debt) Net Cash Growth | 1,068 | 1,059 | 321.15 | 914.91 | 349.56 | 9.63 |
Net Cash Growth | 12.08% | 229.68% | -64.90% | 161.73% | 3529.53% | -98.24% |
Net Cash Per Share Net Cash Per Share Growth | 2.62 | 2.60 | 0.78 | 2.21 | 0.86 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18.97 | 22.29 | 62.34 | 181.01 | 103.66 | 4.65 |
Capital Expenditures CapEx Growth | -48.36 | -49.48 | -54.46 | -30.74 | -81.45 | -106.31 |
Free Cash Flow Free Cash Flow Growth | -29.4 | -27.19 | 7.88 | 150.28 | 22.21 | -101.66 |
Free Cash Flow Growth | - | - | -94.75% | 576.62% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.00% | 41.81% | 25.69% | 51.82% | 46.34% | 47.52% |
Operating Margin | -14.42% | -9.85% | -23.35% | 18.26% | 15.24% | 30.01% |
Pretax Margin | -11.56% | -5.74% | -15.40% | 24.92% | 30.81% | 44.90% |
Profit Margin | -10.76% | -5.22% | -16.24% | 22.19% | 27.55% | 38.77% |
FCF Margin | -6.44% | -5.81% | 1.64% | 20.12% | 3.12% | -11.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | - | 0.250 | 0.300 | 0.125 | 0.300 |
Dividend Per Share Growth | -16.67% | - | -16.67% | 140.00% | -58.33% | 20.00% |
Dividend Yield | 2.14% | - | 1.82% | 1.51% | 0.40% | 0.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 50.01 | 66.70 | 46.24 |
P/FCF Ratio | - | - | 710.64 | 55.16 | 589.21 | - |
PS Ratio | 10.29 | 12.88 | 11.67 | 11.10 | 18.38 | 17.93 |